We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Second Non-Human Primate Genome Sequenced

By Biotechdaily staff writers
Posted on 27 Feb 2006
A multi-center team has completed the draft genome sequence of the rhesus macaque monkey (Macaca mulatta).

The rhesus macaque is the second non-human primate, after the chimpanzee (Pan troglodyte), to have its genome sequenced, and is the first of the Old World monkeys to have its DNA deciphered. More...
Overall, the rhesus genome shares about 92-95% of its sequence with the human (Homo sapiens) genome and more than 98% with the chimpanzee.

The sequencing of the rhesus genome was conducted at the Baylor College of Medicine Human Genome Sequencing Center in Houston (TX, USA), the Genome Sequencing Center at Washington University
(St. Louis, MO, USA), and the J. Craig Venter Institute (Rockville, MD USA), which are all part of the Large Scale Sequencing Research Network of the U.S. National Human Genome Research Institute (NHGRI, Bethesda, MD, USA). The DNA samples used in the sequencing came from a female rhesus macaque at the Southwest Foundation for Biomedical Research (San Antonio, TX, USA).

Independent assemblies of the rhesus genome data were carried out at each of the three sequencing centers using different and complementary approaches. A team led by Granger Sutton, Ph.D., at the J. Craig Venter Institute, joined the data into a single, high-density draft, or "melded assembly.” This new, high-quality assembly, which covers 3% of the rhesus genome, will enable researchers to make evolutionary comparisons and gene predictions for this important organism.

The rhesus macaque is the major non-human primate used for the study of human disease and also has an important role in drug development. In addition, due to its response to the simian immunodeficiency virus (SIV), the rhesus is considered to be the best animal model for studying human immunodeficiency virus (HIV) infection. It also serves as a valuable model for studying other human infectious diseases and for vaccine research. Sequencing is also underway on the genomes of a number of other primates, including the orangutan, marmoset and gorilla.



Related Links:
NHGRI

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Manual Pipetting Aid
Pipette Controllers macro
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.